Daily SPAC Update – December 4, 2024

by | Dec 4, 2024

Global Star (GLST) Extension Approved. APXI Extension Vote Today. ATMC Updates Trust Numbers. LATG Deal Vote Set for Dec 23. ATMV, SHAP, TRON, INAQ Set Extension Votes.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC Daily Brief – December 4, 2024
Tavia Acquisition Corp. (TAVI) launches a $100M IPO today, while APX Acquisition Corp I (APXI) holds an extension vote to prolong its deadline to December 9, 2025. Global Star Acquisition Inc. (GLST) secured its extension to June 22, 2025, with 756,131 redemptions and a trust at $11.39. Several SPACs have upcoming key votes, including Chenghe Acquisition I Co (LATG) on December 23 for its deal, and Alphavest (ATMV), Spree (SHAP), and Corner Growth (TRON) for extensions. Meanwhile, AI Transportation (AITR) terminated its deal, and Alphatime (ATMC) updated its trust to $11.40.

NEW SPAC IPOs
Dec 04: TAVI – Tavia Acquisition Corp. $100M IPO

EXTENSION VOTES
APXI – APX ACQUISITION CORP I * vote December 4, 2024 -> extend to December 9, 2025

SPAC VOTE RESULTS
GLST – GLOBAL STAR ACQUISITION INC * Extend to Jun 22, 2025 * 756,131 redeemed * trust $11.39

SPAC DEAL & EXTENSION VOTES SET
LATG – Chenghe Acquisition I Co * DEAL VOTE SET: Dec 23, 2024 * trust $11.43
ATMV – Alphavest Acquisition Corp * EXTENSION VOTE SET: Dec 18, 2024 * trust $11.34
SHAP – Spree Acquisition Corp 1 Ltd * EXTENSION VOTE SET: Dec 17, 2024 * trust $11.48
TRON – Corner Growth Acquisition Corp 2 * EXTENSION VOTE SET: Dec 23, 2024 * trust $11.94
INAQ – Insight Acquisition Corp * EXTENSION VOTE SET: Dec 06, 2024 * trust $11.28

OTHER SPAC NEWS
ATMC – ALPHATIME ACQUISITION CORP * Trust Update * trust $11.40
AITR – AI TRANSPORTATION ACQUISITION CORP * Deal Termination
AFJK – AIMEI HEALTH TECHNOLOGY CO LTD * Vote to Adjust Trust

Recent Analysis

Daily SPAC Update – January 16, 2025

LATG DeSPACs to Femco Steel Technology (KBSX). Plum Acquisition III Extension Vote. RRAC and EVGR Extension Votes Set. NOEM Separate Trading on Jan 16. 

Daily SPAC Update – January 15, 2025

$150M Plum Acquisition IV and $50M Ribbon Acquisition SPAC IPOs. Aimfinity (AIMAU) and Quetta (QETA) Extensions Approved. Bowen (BOWN) + Qianzhi BioTech Deal Approved. 

Daily SPAC Update – January 14, 2025

Cohen Circle (CCIR) LOI with Ukranian Firm. BRKH DeSPACs to Blaize (BZAI). PPYA Extension Vote. Aimfinity Extends to Oct 2025. Bowen Acquisition (BOWN) Forward Purchase Agreement. 

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.